arrow
M

Matthew M. Hsieh

nih national cancer institute (nci)
H指数:44
被引数:6,288

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Malaria Screening and Treatment in Hematopoietic Cell Transplant Donors and Sickle Cell Disease Candidates/Recipients: A Case Series Using Malaria Polymerase Chain Reaction Testing and a Literature Review

疟疾筛查和治疗在造血细胞移植供者和镰状细胞病候选者/受者中的应用:一项使用疟疾聚合酶链反应检测的病例系列及文献综述

2025-11-280
OAAI
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine model

CRISPR-Cas9、慢病毒转导和碱基编辑技术在镰状细胞病小鼠模型中的比较分析

2025-10-300
OAAI
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years

聚合酶链式反应(PCR)在异基因造血细胞移植后弓形虫病诊断与管理中的有效性与局限性:单中心16年经验,涉及31例患者

2025-08-050
OAAI
Fertility Preservation Outcomes for People with Ovaries and Sickle Cell Anemia: A Multi-Center Study

卵巢患者和镰状细胞贫血患者的生育力保存结局:一项多中心研究

BLOOD
IF23.1
2024-11-050
PRE
In vivo measurement of RBC survival in patients with sickle cell disease before or after hematopoietic stem cell transplantation
2024-04-091
OAAI
Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease

重组药物再利用库的表型筛选发现治疗镰状细胞病的新药

2022-09-2615
OAAI
Safety of liver biopsy in patients with sickle cell related liver disease: A single-center experience

镰状细胞相关肝病患者肝活检的安全性: 单中心经验

2022-04-192
OAAI